ORIC Pharmaceuticals, Inc.

ORIC · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$49,668$75,864$49,334$59,406
Short-Term Investments$237,472$206,649$154,389$196,554
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$8,454$8,611$7,710$6,290
Total Curr. Assets$295,594$291,124$211,433$262,250
Property Plant & Equip (Net)$2,559$2,762$3,021$2,924
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$125,908$45,216$20,039$0
Tax Assets$0$0$0$0
Other NC Assets$7,131$7,755$8,365$8,968
Total NC Assets$135,598$55,733$31,425$11,892
Other Assets$0$0$0$0
Total Assets$431,192$346,857$242,858$274,142
Liabilities
Payables$2,900$3,130$5,160$1,548
Short-Term Debt$3,301$3,273$3,213$3,183
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$13,978$11,647$9,244$20,115
Total Curr. Liab.$20,179$18,050$17,617$24,846
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,094$4,812$5,503$6,174
Total NC Liab.$4,094$4,812$5,503$6,174
Other Liabilities$0$0$0$0
Cap. Leases$3,301$3,273$3,213$3,183
Total Liabilities$24,273$22,862$23,120$31,020
Equity
Pref Stock$0$0$0$0
Common Stock$11$9$7$7
Retained Earnings-$661,737-$629,150-$592,795-$562,774
AOCI$615$187$209$379
Other Equity$1,068,030$952,949$812,317$805,510
Total Equity$406,919$323,995$219,738$243,122
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$431,192$346,857$242,858$274,142
Net Debt-$46,367-$72,591-$46,121-$56,223